Guidance
Introduction of spinal muscular atrophy (SMA) screening in England: Frequently asked questions (FAQs)
These FAQs explain spinal muscular atrophy (SMA), the benefits and limits of early treatment, how screening will work, and what families can expect.
Applies to England
Documents
Details
The NHS in England is introducing spinal muscular atrophy (SMA) screening through a phased NHS in-service evaluation beginning in October 2026. These FAQs explain SMA, how screening will work, what treatments are available, and what families can expect.
Updates to this page
Published 30 September 2026